volume 69 issue 6 pages 56-63

Preclinical Study of the Imaging Properties of the Mn(Ii)–D-Myo-Inositol-1, 2, 3, 4, 5, 6- Hexakisdihydrophosphoric Acid Complex as a Hepatospecific Paramagnetic Contrast Agent

W. Yu. Ussov
M L Belyanin
O.Y. Borodin
A I Bezlepkin
A A Churin
N L Shimanovsky
Publication typeJournal Article
Publication date2024-12-16
scimago Q4
SJR0.152
CiteScore0.4
Impact factor
ISSN10246177, 26189615
Abstract

Purpose: We tried to create a hepatospecific paramagnetic contrast agent – a paramagnetic analogue of 99mTc-technefit, by obtaining a paramagnetic Mn(II) complex with phytic (D-myo-inositol-1, 2, 3, 4, 5, 6– hexakisdihydrophosphoric) acid. Material and methods: A hepatotropic magnetic resonance contrast compound was obtained as an aqueous solution containing a paramagnetic Mn(II) complex with D-myo-inositol-1, 2, 3, 4, 5, 6-hexakis dihydrophosphoric (phytic) acid in a concentration of 0.5 M, with the addition of a 0.5M aqueous solution of meglumine (N-methylglucamine) in a ratio of 1:4 by volume to maintain pH in the range of 6.2–7.8, as well as to improve the stability of the solution. The working name of the Mn(II) complex with phytic acid phytomang®. The toxicological properties of the compound were evaluated when administered to laboratory mice, R1 relaxation and imaging properties in Wistar laboratory rats weighing 350-400 g, using low-field (field strength 0.2 T) and high-field (field strength 1.5 T) MR tomographs. Results: For 0.5 M of an aqueous solution of Mn-phytate, with the addition of meglumine, LD50, when administered acutely to laboratory animals – mice, is more than 18.7 ml / kg of body weight, which allows this compound to be classified according to GOST 12.1.007-76 standards to group 4 – low-hazard substances. The thermodynamic stability constant was 17.5. Spin-lattice relaxivity R1 in aqueous solution at a field strength of 0.2T: R1 = 6.82 1/ms. After intravenous administration to healthy rats with preserved liver function, Mn-phytate is distributed in the bloodstream, with rapid absorption within 5 minutes by liver tissue, followed by partial (up to 7 ± 3 % of the dose) excretion into bile after 30 minutes or more. The total uptake of the drug by the liver is 72 ± 7 % of the administered dose. Conclusion: The complex compound Mn (II) with D-myo-inositol-1, 2, 3, 4, 5, 6– hexakis dihydrophosphoric (phytic) acid belongs to low-toxic substances, is stable in aqueous media and has a high relaxability R1, selectively accumulates and intensively contrasts the liver parenchyma, and can be considered as the basis for creating a hepatospecific paramagnetic contrast preparation for use in MRI diagnostics liver in experimental and clinical studies.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Share
Cite this
GOST |
Cite this
GOST Copy
Ussov W. Y. et al. Preclinical Study of the Imaging Properties of the Mn(Ii)–D-Myo-Inositol-1, 2, 3, 4, 5, 6- Hexakisdihydrophosphoric Acid Complex as a Hepatospecific Paramagnetic Contrast Agent // Medical Radiology and Radiation Safety. 2024. Vol. 69. No. 6. pp. 56-63.
GOST all authors (up to 50) Copy
Ussov W. Y., Belyanin M. L., Borodin O., Bezlepkin A. I., Churin A. A., Shimanovsky N. L. Preclinical Study of the Imaging Properties of the Mn(Ii)–D-Myo-Inositol-1, 2, 3, 4, 5, 6- Hexakisdihydrophosphoric Acid Complex as a Hepatospecific Paramagnetic Contrast Agent // Medical Radiology and Radiation Safety. 2024. Vol. 69. No. 6. pp. 56-63.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.33266/1024-6177-2024-69-6-56-63
UR - https://medradiol.fmbafmbc.ru/vypuski/10-vypuski-zhurnalov/1815-56-63_ussov_rus
TI - Preclinical Study of the Imaging Properties of the Mn(Ii)–D-Myo-Inositol-1, 2, 3, 4, 5, 6- Hexakisdihydrophosphoric Acid Complex as a Hepatospecific Paramagnetic Contrast Agent
T2 - Medical Radiology and Radiation Safety
AU - Ussov, W. Yu.
AU - Belyanin, M L
AU - Borodin, O.Y.
AU - Bezlepkin, A I
AU - Churin, A A
AU - Shimanovsky, N L
PY - 2024
DA - 2024/12/16
PB - Burnasyan Federal Medical Biophysical Center Of Federal Medical Biological Agency
SP - 56-63
IS - 6
VL - 69
SN - 1024-6177
SN - 2618-9615
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Ussov,
author = {W. Yu. Ussov and M L Belyanin and O.Y. Borodin and A I Bezlepkin and A A Churin and N L Shimanovsky},
title = {Preclinical Study of the Imaging Properties of the Mn(Ii)–D-Myo-Inositol-1, 2, 3, 4, 5, 6- Hexakisdihydrophosphoric Acid Complex as a Hepatospecific Paramagnetic Contrast Agent},
journal = {Medical Radiology and Radiation Safety},
year = {2024},
volume = {69},
publisher = {Burnasyan Federal Medical Biophysical Center Of Federal Medical Biological Agency},
month = {dec},
url = {https://medradiol.fmbafmbc.ru/vypuski/10-vypuski-zhurnalov/1815-56-63_ussov_rus},
number = {6},
pages = {56--63},
doi = {10.33266/1024-6177-2024-69-6-56-63}
}
MLA
Cite this
MLA Copy
Ussov, W. Yu., et al. “Preclinical Study of the Imaging Properties of the Mn(Ii)–D-Myo-Inositol-1, 2, 3, 4, 5, 6- Hexakisdihydrophosphoric Acid Complex as a Hepatospecific Paramagnetic Contrast Agent.” Medical Radiology and Radiation Safety, vol. 69, no. 6, Dec. 2024, pp. 56-63. https://medradiol.fmbafmbc.ru/vypuski/10-vypuski-zhurnalov/1815-56-63_ussov_rus.